Scientists have developed a new approach for treating a deadly brain cancer that strikes 15,000 in the United States annually and for which there is no effective long-term therapy. They have shown that the approach extends the lives of laboratory animals and are preparing to seek government approval for a human clinical trial. By using an ultra-small drug-delivery particle that nimbly navigates brain tissue, researchers have developed a new approach to treating brain cancer that has been shown to extend the lives of laboratory animals.
Posted on: Thu, 04 Jul 2013 14:05:06 +0000
Trending Topics
Recently Viewed Topics
© 2015